Saturday, November 2, 2024

Cannabis & CBD Pharma News

Medical Cannabis Network brings you the latest medical cannabis & CBD pharma news from across the medicinal cannabis, CBD & THC drug development sector.

Cannabis nursing in the USA

Cannabis nursing in the USA

American Cannabis Nurses Association President Eloise Theisen speaks to MCN about cannabis research, policy and clinical practice. Eloise Theisen is President of the American Cannabis...
UK medical cannabis dermatology service launched for skin conditions

UK medical cannabis dermatology service launched for skin conditions

Sapphire Medical Clinics is offering the UK’s first medical cannabis dermatology service for patients with rare and challenging skin conditions. Patients with skin conditions such...
Successful initial results using cannabis terpenes to treat COVID-19

Successful initial results using cannabis terpenes to treat COVID-19

A study to test the efficacy of a unique cannabis terpene formulation for the treatment of viral infections, including COVID-19, has shown early promising...
Cannabinoid therapies aim to address unmet medical needs

Cannabinoid therapies aim to address unmet medical needs

Oxford Cannabinoid Technologies (OCT) has appointed a new Chief Scientific Officer to help deliver cannabinoid therapies for unmet medical needs. Dr Valentino Parravicini, PhD will...
First medical cannabis patient to receive funding for one year

First medical cannabis patient to receive funding for one year

Sapphire Medical Foundation has announced its first patient has secured medicine funding for one year. Two years following the rescheduling of cannabis-based medicinal products in...
A deep dive into Drug Science’s Project Twenty21

A deep dive into Drug Science’s Project Twenty21

Clinical Director Dr Chloe Sakal and Project Director Amelia Middlemiss give an update on the progress of Drug Science’s groundbreakingly ambitious Project Twenty21 programme. On...
Expanding the boundaries of medical cannabis clinical evidence

Expanding the boundaries of medical cannabis clinical evidence

Expanding the boundaries of medical cannabis clinical evidence; removing barriers to medical cannabis practice. In this article, Amit Sade, of Sade Group, discusses expanding medical...
Shipping medical cannabis: a Dutch perspective

Shipping medical cannabis: a Dutch perspective

Malti Ramdharie of CIBG tells MCN about the shipping and supply of medical cannabis in the Netherlands. Dutch patients have been able to access medical...
Medical cannabis treatment in the UK with Professor Mike Barnes

Medical cannabis treatment in the UK with Professor Mike Barnes

Medical cannabis expert Professor Mike Barnes discusses Medical cannabis treatment and highlights the challenges facing cannabis in the UK. Consultant neurologist and medical cannabis treatment...
Sanity Group: unlocking the health benefits of cannabinoid medicines

Sanity Group: unlocking the health benefits of cannabinoid medicines

Sanity Group puts people first to improve patient access and drive innovation, and utilises the health benefits of cannabinoid medicines. Putting people first, as well...
Free medical cannabis education platform launched in the UK

Free medical cannabis education platform launched in the UK

A free medical cannabis education platform has been launched by Sapphire Medical Clinics in response to a recommendation by The National Institute for Health...
Education, development, and campaigning for patient access to medical cannabis

Education, development, and campaigning for patient access to medical cannabis

Althea’s mission is to alleviate the suffering of patients with debilitating conditions through education, development, and campaigning for patient access to medical cannabis. The primary...
UK Medical Cannabis Registry launched today by Sapphire Medical Clinics

UK Medical Cannabis Registry launched today by Sapphire Medical Clinics

Today marks the launch of Sapphire Medical Clinic’s Medical Cannabis Registry for patients in the UK. Sapphire Medical Clinics has today launched its Medical Cannabis...
CBD and inflammatory bowel disease: not just a gut feeling

CBD and inflammatory bowel disease: not just a gut feeling

IcBD has developed a CBD formulation which could be the answer to inflammatory bowel disease. In recent years, few topics have been as hot and...
Materia officially enters the German medical cannabis market

Materia officially enters the German medical cannabis market

Materia has now acquired the licensed medical cannabis distributor, Cannaktiv, and has officially entered the German medical cannabis market. Materia, a medical cannabis and wellness...
Effects of CBD oil on mental health: anxiety disorders

Effects of CBD oil on mental health: anxiety disorders

In this article Keith Myers explores the effect that CBD oil has on mental health and anxiety disorders. In 2017, 3.8% of the global population...
Could cannabis terpene formulation treat COVID-19?

Could cannabis terpene formulation treat COVID-19?

A unique formulation of cannabis terpenes is being tested for its efficacy in treating viral infections, including COVID-19. The cannabis terpene formulation is uniquely dedicated...
Exploring the extraction and applications of CBDA

Exploring the extraction and applications of CBDA

We all know about CBD – but what do we know about CBDA? When we think about the cannabinoids that can be found in cannabis...
CBD in medicine: relief and regulation

CBD in medicine: relief and regulation

Neuropharmacologist and Functional Medicine practitioner Dr Elisabeth Philipps tells MCN about the therapeutic benefits of CBD and talks about CBD regulation. MCN speaks to Dr...
Professor David Finn discusses cannabinoids in the treatment of pain

Professor David Finn discusses cannabinoids in the treatment of pain

Professor David Finn of the National University of Ireland Galway discusses the use of cannabinoids in the treatment of pain. In March, Medical Cannabis Network...

Featured Special Reports

Pin It on Pinterest